HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.

Abstract
Arglabin [1(R),10(S)-epoxy-5(S),5(S),7(S)-guaia-3(4),11(13)-dien-6, 12-olide], a sesquiterpene gamma-lactone is isolated from Artemisia glabella, a species of wormwood endemic to the Karaganda region of Kazakstan. The compound has been modified to render it water-soluble through addition of a dimethylaminohydrochloride group to the C(13) carbohydride moiety to yield Arglabin-DMA. Arglabin-DMA is a registered antitumor substance in the Republic of Kazakstan. Previously, we have shown that this compound prevents protein farnesylation without altering geranylgeranylation. We now report that Arglabin-DMA inhibits the incorporation of [(3)H]farnesylpyrophosphate into human H-ras protein by FTase with an IC(50) of no greater than 25 microM. Kinetic studies show that the phosphorylated form of this compound competitively inhibits the binding of farnesyl diphosphate to FTase. This mechanism of action is different from other reported peptidomimetic FTIs which lower the affinity of ras protein to FTase. Our in vitro studies confirm that Arglabin-DMA inhibits post-translational modification of ras protein in cells. Arglabin-DMA inhibits anchorage-dependent proliferation of NB cells (IC50=10 microg/ml) and inhibits anchorage-independent growth of NB and KNRK cells with about the same IC(50). Soft-agar colony formation assay of H-ras and K-ras transformed cells show IC(50)s to be 2 and 5 microg/ml, respectively. In primary cultures of human tumor cells, Arglabin-DMA inhibits cell proliferation of a variety of tumor types with IC(90)s in the range of 0.85 to 5.0 microg/ml. Because of these pharmacologic properties, we propose that Arglabin-DMA is suitable for the treatment of ras related malignancies.
AuthorsT E Shaikenov, S M Adekenov, R M Williams, N Prashad, F L Baker, T L Madden, R Newman
JournalOncology reports (Oncol Rep) 2001 Jan-Feb Vol. 8 Issue 1 Pg. 173-9 ISSN: 1021-335X [Print] Greece
PMID11115593 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • Polyisoprenyl Phosphates
  • Sesquiterpenes
  • Sesquiterpenes, Guaiane
  • arglabin-dimethylaminohydrochloride
  • farnesyl pyrophosphate
  • arglabin
  • Alkyl and Aryl Transferases
  • Farnesyltranstransferase
  • Proto-Oncogene Proteins p21(ras)
Topics
  • 3T3 Cells (drug effects)
  • Alkyl and Aryl Transferases (antagonists & inhibitors)
  • Animals
  • Antineoplastic Agents, Phytogenic (chemistry, pharmacology)
  • Artemisia (chemistry)
  • Binding, Competitive
  • Cell Division (drug effects)
  • Cell Line, Transformed (drug effects)
  • Cell Transformation, Neoplastic
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Farnesyltranstransferase
  • Mice
  • Molecular Structure
  • Neoplasm Proteins (antagonists & inhibitors, metabolism)
  • Neoplasms (pathology)
  • Neuroblastoma (pathology)
  • Plants, Medicinal
  • Polyisoprenyl Phosphates (metabolism)
  • Protein Prenylation (drug effects)
  • Protein Processing, Post-Translational (drug effects)
  • Proto-Oncogene Proteins p21(ras) (metabolism)
  • Sesquiterpenes (pharmacology)
  • Sesquiterpenes, Guaiane
  • Solubility
  • Tumor Cells, Cultured (drug effects)
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: